Auvi Labs develops Beacon, a non-invasive wearable device focused on patient monitoring. This technology is specifically engineered for the early detection of dialysis access failure. The device provides clinicians with timely alerts to proactively manage vascular access complications.
Funding
Funding not disclosed
Founders
Product
Problem
Dialysis access failure, such as stenosis or thrombosis, often progresses asymptomatically until a critical event occurs, necessitating emergency interventions and leading to significant patient morbidity. Current monitoring methods are typically intermittent, relying on manual palpation or Doppler ultrasound, which can miss early signs of dysfunction.
Solution
Auvi Labs' Beacon is a non-invasive wearable device that continuously monitors vascular access for hemodialysis patients. The device utilizes advanced sensor technology to detect subtle physiological changes indicative of impending access failure. By providing real-time data and predictive analytics, Beacon enables proactive intervention, preventing critical events and improving patient outcomes. This continuous monitoring facilitates early detection of complications, reducing the need for emergency procedures and hospitalizations.
Target Audience
The primary target audience includes nephrologists, vascular surgeons, dialysis centers, and hospital systems focused on improving the management of hemodialysis patients.
Features
- Non-invasive wearable sensor array for continuous physiological monitoring of vascular access sites.
- Proprietary algorithms for detecting early indicators of stenosis and thrombosis.
- Real-time data transmission to a secure cloud platform for analysis.
- Predictive analytics engine to forecast potential access failure events.
- User-friendly interface for healthcare providers to review patient data and alerts.
- Integration capabilities with existing patient management systems.